LAURA CUNNINGHAM: Open Payments
NPI 1326680893 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$94 in 5 payments from 4 companies in 2025. Trend: 2023 $126 · 2024 $170 · 2025 $94
Food & beverage: $94
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $40 |
| Celgene Corporation | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $16 |
Products named: NUCALA, REBLOZYL, TEZSPIRE, Trodelvy.
Industry payments across MO — which companies pay providers there.
